<table-wrap xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" id="table2" position="float"><label>Table 2.</label><caption><title>Age-adjusted seroprevalence by MIA in participants aged over 16 in the general population of the Society Islands in French Polynesia, based on serosurveys conducted in 2014 (<italic>n</italic>&#160;=&#160;48) and 2015 (<italic>n</italic>&#160;=&#160;672).</title></caption><table frame="hsides" rules="groups"><thead><tr><th valign="bottom">Virus</th><th valign="bottom">2014 seroprevalence (95% CI)</th><th valign="bottom">2014 age-adjusted seroprevalence (95% CI)</th><th valign="bottom">2015 seroprevalence (95% CI)</th><th valign="bottom">2015 age-adjusted (95% CI)</th></tr></thead><tbody><tr><td valign="bottom">DENV1</td><td valign="bottom">85 (72&#8211;94)</td><td valign="bottom">83 (55&#8211;100)</td><td valign="bottom">80 (77&#8211;83)</td><td valign="bottom">80 (71&#8211;91)</td></tr><tr><td valign="bottom">DENV2</td><td valign="bottom">48 (33&#8211;62)</td><td valign="bottom">50 (28&#8211;87)</td><td valign="bottom">19 (16&#8211;22)</td><td valign="bottom">21 (15&#8211;21)</td></tr><tr><td valign="bottom">DENV3</td><td valign="bottom">75 (60&#8211;86)</td><td valign="bottom">72 (47&#8211;100)</td><td valign="bottom">56 (52&#8211;60)</td><td valign="bottom">55 (48&#8211;64)</td></tr><tr><td valign="bottom">DENV4</td><td valign="bottom">63 (47&#8211;76)</td><td valign="bottom">65 (40&#8211;100)</td><td valign="bottom">42 (38&#8211;46)</td><td valign="bottom">45 (38&#8211;54)</td></tr><tr><td valign="bottom">ZIKV</td><td valign="bottom">35 (22&#8211;50)</td><td valign="bottom">32 (16&#8211;62)</td><td valign="bottom">21 (18&#8211;25)</td><td valign="bottom">26 (20&#8211;34)</td></tr></tbody></table><table-wrap-foot><fn><p><sup>*</sup>chi-squared test comparing 2014 bootstrap estimates with 2015 results.</p></fn></table-wrap-foot></table-wrap>